← Eichor
Condition: Hypercholesterolemia And Hyperlipidemia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hypercholesterolemia And Hyperlipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers
NA · 2 location(s) · Fundació Eurecat · NCT06422741Screening for Familial Hypercholesterolemia in Children
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT065551202-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT04941599Comparing Direct vs Indirect Methods for Cascade Screening
NA · 1 location(s) · University of Maryland, Baltimore · NCT05348564Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
NA · 1 location(s) · Washington University School of Medicine · NCT06894004Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
NA · 1 location(s) · Midwest Center for Metabolic and Cardiovascular Research · NCT07514663Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NA · 2 location(s) · University of Tennessee · NCT06374277A Dose-exploration Study of EDP167 in HoFH
Phase 2 · 1 location(s) · Eddingpharm (Zhuhai) Co., Ltd. · NCT07489209IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07473960Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648PMMHRI - Familial Hypercholesterolemia Registry
Phase N/A · 1 location(s) · Polish Mother Memorial Hospital Research Institute · NCT06571630Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Phase 2 · 1 location(s) · Wake Forest University Health Sciences · NCT06488105Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis
NA · 1 location(s) · Abu Dhabi Health Services Company · NCT06535542PMMHRI-Pitavastatin Registry
Phase N/A · 1 location(s) · Polish Mother Memorial Hospital Research Institute · NCT06858982The Spanish Familial Hypercholesterolaemia Cohort Study
Phase N/A · 1 location(s) · Fundación Hipercolesterolemia Familiar · NCT02693548Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NA · 22 location(s) · Stephen Nicholls · NCT05325034Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION
Phase 3 · 52 location(s) · Novartis Pharmaceuticals · NCT05682378A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and
Phase 2 · 26 location(s) · Novartis Pharmaceuticals · NCT07610278Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia
NA · 1 location(s) · Institut Pasteur de Lille · NCT06894251Clinical Decision Support for Familial Hypercholesterolemia
NA · 1 location(s) · University Hospital, Linkoeping · NCT03989167Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
Phase 4 · 10 location(s) · Kowa Company, Ltd. · NCT07634484A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473PET Imaging of Inflammation and Lipid Lowering Study
NA · 1 location(s) · University of Cambridge · NCT04073797A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07543731Complete Lifestyle Medicine Intervention Program
Phase N/A · 1 location(s) · Northern Ontario School of Medicine · NCT06192251Pharmacogenomic Informed Statin Prescribing
NA · 2 location(s) · VA Office of Research and Development · NCT06568601Lipid Transport Disorder Italian Genetic Record (LIPIGEN)
Phase N/A · 1 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT06362473Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Perc
Phase 4 · 115 location(s) · Duke University · NCT06909565
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.